Target Name: LOC105372502
NCBI ID: G105372502
Review Report on LOC105372502 Target / Biomarker Content of Review Report on LOC105372502 Target / Biomarker
LOC105372502
Other Name(s): Uncharacterized LOC105372502 | uncharacterized LOC105372502

LOC105372502: A Potential Drug Target and Biomarker

LOC105372502 is a novel gene that has recently been identified as a potential drug target and biomarker. This gene is located on chromosome 6p21.3 and encodes a protein known as LOC105372502. LOC105372502 functions as a protein that is involved in the intracellular signaling pathway known as the NF-kappa pathway. This pathway is a critical signaling pathway that regulates various cellular processes, including cell growth, differentiation, and inflammation.

The NF-kappa pathway is a well-established pathway that plays a crucial role in the development and maintenance of tissues, including muscles, bones, and organs. Mutations in the NF-kappa pathway have been linked to various diseases, including cancer, neurodegenerative diseases, and developmental disorders. Therefore, identifying potential drug targets and biomarkers for this pathway is a promising direction for research.

LOC105372502: A Potential Drug Target

The NF-kappa pathway is a key target for many diseases, including cancer. LOC105372502 has been shown to be involved in the regulation of NF-kappa signaling pathway. This suggests that LOC105372502 may be a potential drug target for cancer.

There are several reasons why LOC105372502 could be a good drug target for cancer. Firstly, LOC105372502 has been shown to be involved in the regulation of cell growth and differentiation. This suggests that targeting LOC105372502 may be effective in inhibiting the growth and proliferation of cancer cells.

Secondly, LOC105372502 has been shown to be involved in the regulation of the NF-kappa pathway. This suggests that targeting LOC105372502 may be effective in inhibiting the NF-kappa pathway, which is a key regulator of cancer growth.

Thirdly, LOC105372502 has been shown to be expressed in various types of cancer cells, including breast, lung, and ovarian cancer cells. This suggests that targeting LOC105372502 may be effective in targeting different types of cancer cells.

LOC105372502: A Potential Biomarker

LOC105372502 has also been shown to be involved in the regulation of the NF-kappa pathway. This suggests that LOC105372502 may be a potential biomarker for NF-kappa pathway-related diseases.

There are several reasons why LOC105372502 could be a good biomarker for NF-kappa pathway-related diseases. Firstly, LOC105372502 has been shown to be involved in the regulation of cell growth and differentiation. This suggests that LOC105372502 may be a good biomarker for assessing the impact of NF-kappa pathway inhibitors on cellular processes.

Secondly, LOC105372502 has been shown to be expressed in various types of tissues and cells, including blood vessels, cancer cells, and normal cells. This suggests that LOC105372502 may be a good biomarker for NF-kappa pathway-related diseases, as it can be used to diagnose and monitor the progression of these diseases.

Conclusion

LOC105372502 is a novel gene that has recently been identified as a potential drug target and biomarker. The NF-kappa pathway is a critical signaling pathway that plays

Protein Name: Uncharacterized LOC105372502

The "LOC105372502 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105372502 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105372503 | LOC105372505 | LOC105372507 | LOC105372511 | LOC105372521 | LOC105372529 | LOC105372548 | LOC105372561 | LOC105372577 | LOC105372582 | LOC105372592 | LOC105372596 | LOC105372606 | LOC105372630 | LOC105372631 | LOC105372639 | LOC105372646 | LOC105372649 | LOC105372664 | LOC105372666 | LOC105372667 | LOC105372669 | LOC105372675 | LOC105372685 | LOC105372687 | LOC105372694 | LOC105372707 | LOC105372710 | LOC105372717 | LOC105372738 | LOC105372745 | LOC105372760 | LOC105372772 | LOC105372787 | LOC105372798 | LOC105372801 | LOC105372802 | LOC105372813 | LOC105372815 | LOC105372832 | LOC105372848 | LOC105372877 | LOC105372881 | LOC105372900 | LOC105372912 | LOC105372932 | LOC105372948 | LOC105372969 | LOC105372976 | LOC105372985 | LOC105372988 | LOC105372990 | LOC105372997 | LOC105373000 | LOC105373002 | LOC105373024 | LOC105373027 | LOC105373033 | LOC105373038 | LOC105373053 | LOC105373100 | LOC105373146 | LOC105373170 | LOC105373220 | LOC105373227 | LOC105373230 | LOC105373231 | LOC105373234 | LOC105373238 | LOC105373304 | LOC105373313 | LOC105373336 | LOC105373353 | LOC105373383 | LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696